Organon & Co. (OGN) ROA
- 2026-06-30: ROA 1.59%.
- 2026-03-31: ROA 1.89%.
- 2025-12-31: ROA 1.45%.
- 2025-09-30: ROA 3.70%.
Complete source-backed roa history.
- Available history
- 2020-12-31 to 2026-06-30
- Data captured
Historical ROA
| Date | ROA |
|---|---|
| 2026-06-30 | 1.59% |
| 2026-03-31 | 1.89% |
| 2025-12-31 | 1.45% |
| 2025-09-30 | 3.70% |
| 2025-06-30 | 5.19% |
| 2025-03-31 | 5.70% |
| 2024-12-31 | 6.59% |
| 2024-09-30 | 10.20% |
| 2024-06-30 | 8.23% |
| 2024-03-31 | 8.80% |
| 2023-12-31 | 8.48% |
| 2023-09-30 | 5.31% |
| 2023-06-30 | 6.87% |
| 2023-03-31 | 6.93% |
| 2022-12-31 | 8.37% |
| 2022-09-30 | 9.69% |
| 2022-06-30 | 10.43% |
| 2022-03-31 | 12.27% |
| 2021-12-31 | 12.65% |
| 2021-09-30 | 13.38% |
| 2021-06-30 | 15.96% |
| 2021-03-31 | 19.25% |
| 2020-12-31 | 21.37% |
Annual ROA
| Date | ROA |
|---|---|
| 2025-12-31 | 1.45% |
| 2024-12-31 | 6.59% |
| 2023-12-31 | 8.48% |
| 2022-12-31 | 8.37% |
| 2021-12-31 | 12.65% |
| 2020-12-31 | 21.37% |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IDEAYA Biosciences, Inc. (IDYA) | United States | $3.540B | -20.52 |
| Xenon Pharmaceuticals Inc. (XENE) | $3.684B | -14.27 | |
| ACADIA PHARMACEUTICALS INC (ACAD) | United States | $3.823B | 11.45 |
| Amylyx Pharmaceuticals, Inc. (AMLX) | United States | $3.361B | -13.15 |
| AbCellera Biologics Inc. (ABCL) | $3.879B | -14.59 | |
| Enliven Therapeutics, Inc. (ELVN) | United States | $3.307B | -35.07 |
| Arcutis Biotherapeutics, Inc. (ARQT) | United States | $3.303B | 115.47 |
| Arcus Biosciences, Inc. (RCUS) | United States | $3.188B | -8.52 |
| Dyne Therapeutics, Inc. (DYN) | United States | $3.084B | -7.09 |
| Tango Therapeutics, Inc. (TNGX) | United States | $4.154B | -42.53 |